510(k) K162227

STA® - Liatest® D-Di by Diagnostica Stago — Product Code DAP

K162227 is an FDA 510(k) premarket notification submitted by Diagnostica Stago for the device "STA® - Liatest® D-Di". The FDA issued a decision of Substantially Equivalent on December 10, 2016. The device falls under product code DAP (Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 864.7320. Diagnostica Stago has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 10, 2016
Date Received
August 8, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
864.7320
Review Panel
HE
Submission Type